TRANSFUSION MANAGEMENT OF AN IGA DEFICIENT PATIENT WITH ANTI-IGA AND INCIDENTAL CORRECTION OF IGA DEFICIENCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Rl. Rogers et al., TRANSFUSION MANAGEMENT OF AN IGA DEFICIENT PATIENT WITH ANTI-IGA AND INCIDENTAL CORRECTION OF IGA DEFICIENCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, American journal of hematology, 57(4), 1998, pp. 326-330
A patient with multiple myeloma was noted to have an IgA deficiency du
ring investigation of a possible transfusion reaction due to IgA defic
iency and anti-IgA, Because of the patient's age, otherwise good healt
h, and early stage of disease, he was enrolled in a research treatment
protocol that involved an allogeneic bone marrow transplant (BMT). Th
e BMT successfully put the patient in complete remission from his mult
iple myeloma and corrected his IgA deficiency, Class-specific IgG anti
-IgA antibody that had been identified prior to BMT was no longer dete
ctable in his plasma, Anaphylactic transfusion reactions were successf
ully avoided by using a combination of IgA-deficient and washed blood
components including the marrow graft, and IgA-reduced intravenous imm
unoglobulin. (C) 1998 Wiley-Liss, Inc.